+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bronchiectasis Drugs Market 2023-2027

  • PDF Icon

    Report

  • 168 Pages
  • June 2023
  • Region: Global
  • TechNavio
  • ID: 5681658
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The bronchiectasis drugs market is forecasted to grow by USD 326.01 mn during 2022-2027, accelerating at a CAGR of 9.98% during the forecast period. The report on the bronchiectasis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing cases of associated risk factors, availability of low-cost off-label generics, and surge in geriatric population.

The bronchiectasis drugs market is segmented as below:

By Product

  • Antibiotics
  • Expectorants
  • Others

By Distribution Channel

  • Offline
  • Online

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing awareness about bronchiectasis as one of the prime reasons driving the bronchiectasis drugs market growth during the next few years. Also, advances in the diagnostics of respiratory diseases and rising demand for targeted therapies will lead to sizable demand in the market.

The report on the bronchiectasis drugs market covers the following areas:

  • Bronchiectasis drugs market sizing
  • Bronchiectasis drugs market forecast
  • Bronchiectasis drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bronchiectasis drugs market vendors that include AbbVie Inc., Akorn Operating Co LLC, Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Dr Reddys Laboratories Ltd., Endo International Plc, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Lupin Ltd., Neopharma Corp., Pfizer Inc., Reckitt Benckiser Group Plc, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Virtus Pharmaceuticals LLC, Wockhardt Ltd., and Zydus Lifesciences Ltd.. Also, the bronchiectasis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global bronchiectasis drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global bronchiectasis drugs market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Antibiotics - Market size and forecast 2022-2027
Exhibit 34: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)
6.4 Expectorants - Market size and forecast 2022-2027
Exhibit 38: Chart on Expectorants - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Expectorants - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Expectorants - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Expectorants - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Product
Exhibit 46: Market opportunity by Product ($ million)
Exhibit 47: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 50: Chart on Comparison by Distribution Channel
Exhibit 51: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 52: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 56: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product/Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 Akorn Operating Co LLC
Exhibit 115: Akorn Operating Co LLC - Overview
Exhibit 116: Akorn Operating Co LLC - Product/Service
Exhibit 117: Akorn Operating Co LLC - Key offerings
12.5 Amneal Pharmaceuticals Inc.
Exhibit 118: Amneal Pharmaceuticals Inc. - Overview
Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 120: Amneal Pharmaceuticals Inc. - Key news
Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus
12.6 Aurobindo Pharma Ltd.
Exhibit 123: Aurobindo Pharma Ltd. - Overview
Exhibit 124: Aurobindo Pharma Ltd. - Product/Service
Exhibit 125: Aurobindo Pharma Ltd. - Key offerings
12.7 Bayer AG
Exhibit 126: Bayer AG - Overview
Exhibit 127: Bayer AG - Business segments
Exhibit 128: Bayer AG - Key news
Exhibit 129: Bayer AG - Key offerings
Exhibit 130: Bayer AG - Segment focus
12.8 Boehringer Ingelheim International GmbH
Exhibit 131: Boehringer Ingelheim International GmbH - Overview
Exhibit 132: Boehringer Ingelheim International GmbH - Business segments
Exhibit 133: Boehringer Ingelheim International GmbH - Key news
Exhibit 134: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 135: Boehringer Ingelheim International GmbH - Segment focus
12.9 Dr Reddys Laboratories Ltd.
Exhibit 136: Dr Reddys Laboratories Ltd. - Overview
Exhibit 137: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 138: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 139: Dr Reddys Laboratories Ltd. - Segment focus
12.10 Endo International Plc
Exhibit 140: Endo International Plc - Overview
Exhibit 141: Endo International Plc - Business segments
Exhibit 142: Endo International Plc - Key news
Exhibit 143: Endo International Plc - Key offerings
Exhibit 144: Endo International Plc - Segment focus
12.11 GlaxoSmithKline Plc
Exhibit 145: GlaxoSmithKline Plc - Overview
Exhibit 146: GlaxoSmithKline Plc - Business segments
Exhibit 147: GlaxoSmithKline Plc - Key news
Exhibit 148: GlaxoSmithKline Plc - Key offerings
Exhibit 149: GlaxoSmithKline Plc - Segment focus
12.12 Hikma Pharmaceuticals Plc
Exhibit 150: Hikma Pharmaceuticals Plc - Overview
Exhibit 151: Hikma Pharmaceuticals Plc - Business segments
Exhibit 152: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 153: Hikma Pharmaceuticals Plc - Segment focus
12.13 Lupin Ltd.
Exhibit 154: Lupin Ltd. - Overview
Exhibit 155: Lupin Ltd. - Product/Service
Exhibit 156: Lupin Ltd. - Key news
Exhibit 157: Lupin Ltd. - Key offerings
12.14 Neopharma Corp.
Exhibit 158: Neopharma Corp. - Overview
Exhibit 159: Neopharma Corp. - Product/Service
Exhibit 160: Neopharma Corp. - Key news
Exhibit 161: Neopharma Corp. - Key offerings
12.15 Pfizer Inc.
Exhibit 162: Pfizer Inc. - Overview
Exhibit 163: Pfizer Inc. - Product/Service
Exhibit 164: Pfizer Inc. - Key news
Exhibit 165: Pfizer Inc. - Key offerings
12.16 Reckitt Benckiser Group Plc
Exhibit 166: Reckitt Benckiser Group Plc - Overview
Exhibit 167: Reckitt Benckiser Group Plc - Business segments
Exhibit 168: Reckitt Benckiser Group Plc - Key offerings
Exhibit 169: Reckitt Benckiser Group Plc - Segment focus
12.17 Viatris Inc.
Exhibit 170: Viatris Inc. - Overview
Exhibit 171: Viatris Inc. - Business segments
Exhibit 172: Viatris Inc. - Key news
Exhibit 173: Viatris Inc. - Key offerings
Exhibit 174: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 175: Inclusions checklist
Exhibit 176: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 177: Currency conversion rates for US$
13.4 Research methodology
Exhibit 178: Research methodology
Exhibit 179: Validation techniques employed for market sizing
Exhibit 180: Information sources
13.5 List of abbreviations
Exhibit 181: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global bronchiectasis drugs market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Expectorants - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Expectorants - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Expectorants - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Expectorants - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by Product ($ million)
Exhibits 47: Data Table on Market opportunity by Product ($ million)
Exhibits 48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 50: Chart on Comparison by Distribution Channel
Exhibits 51: Data Table on Comparison by Distribution Channel
Exhibits 52: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits 60: Market opportunity by Distribution Channel ($ million)
Exhibits 61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2022 and 2027
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: AbbVie Inc. - Overview
Exhibits 112: AbbVie Inc. - Product/Service
Exhibits 113: AbbVie Inc. - Key news
Exhibits 114: AbbVie Inc. - Key offerings
Exhibits 115: Akorn Operating Co LLC - Overview
Exhibits 116: Akorn Operating Co LLC - Product/Service
Exhibits 117: Akorn Operating Co LLC - Key offerings
Exhibits 118: Amneal Pharmaceuticals Inc. - Overview
Exhibits 119: Amneal Pharmaceuticals Inc. - Business segments
Exhibits 120: Amneal Pharmaceuticals Inc. - Key news
Exhibits 121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits 122: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits 123: Aurobindo Pharma Ltd. - Overview
Exhibits 124: Aurobindo Pharma Ltd. - Product/Service
Exhibits 125: Aurobindo Pharma Ltd. - Key offerings
Exhibits 126: Bayer AG - Overview
Exhibits 127: Bayer AG - Business segments
Exhibits 128: Bayer AG - Key news
Exhibits 129: Bayer AG - Key offerings
Exhibits 130: Bayer AG - Segment focus
Exhibits 131: Boehringer Ingelheim International GmbH - Overview
Exhibits 132: Boehringer Ingelheim International GmbH - Business segments
Exhibits 133: Boehringer Ingelheim International GmbH - Key news
Exhibits 134: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 135: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 136: Dr Reddys Laboratories Ltd. - Overview
Exhibits 137: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 138: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 139: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 140: Endo International Plc - Overview
Exhibits 141: Endo International Plc - Business segments
Exhibits 142: Endo International Plc - Key news
Exhibits 143: Endo International Plc - Key offerings
Exhibits 144: Endo International Plc - Segment focus
Exhibits 145: GlaxoSmithKline Plc - Overview
Exhibits 146: GlaxoSmithKline Plc - Business segments
Exhibits 147: GlaxoSmithKline Plc - Key news
Exhibits 148: GlaxoSmithKline Plc - Key offerings
Exhibits 149: GlaxoSmithKline Plc - Segment focus
Exhibits 150: Hikma Pharmaceuticals Plc - Overview
Exhibits 151: Hikma Pharmaceuticals Plc - Business segments
Exhibits 152: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 153: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 154: Lupin Ltd. - Overview
Exhibits 155: Lupin Ltd. - Product/Service
Exhibits 156: Lupin Ltd. - Key news
Exhibits 157: Lupin Ltd. - Key offerings
Exhibits 158: Neopharma Corp. - Overview
Exhibits 159: Neopharma Corp. - Product/Service
Exhibits 160: Neopharma Corp. - Key news
Exhibits 161: Neopharma Corp. - Key offerings
Exhibits 162: Pfizer Inc. - Overview
Exhibits 163: Pfizer Inc. - Product/Service
Exhibits 164: Pfizer Inc. - Key news
Exhibits 165: Pfizer Inc. - Key offerings
Exhibits 166: Reckitt Benckiser Group Plc - Overview
Exhibits 167: Reckitt Benckiser Group Plc - Business segments
Exhibits 168: Reckitt Benckiser Group Plc - Key offerings
Exhibits 169: Reckitt Benckiser Group Plc - Segment focus
Exhibits 170: Viatris Inc. - Overview
Exhibits 171: Viatris Inc. - Business segments
Exhibits 172: Viatris Inc. - Key news
Exhibits 173: Viatris Inc. - Key offerings
Exhibits 174: Viatris Inc. - Segment focus
Exhibits 175: Inclusions checklist
Exhibits 176: Exclusions checklist
Exhibits 177: Currency conversion rates for US$
Exhibits 178: Research methodology
Exhibits 179: Validation techniques employed for market sizing
Exhibits 180: Information sources
Exhibits 181: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global bronchiectasis drugs market: AbbVie Inc., Akorn Operating Co LLC, Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Dr Reddys Laboratories Ltd., Endo International Plc, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Lupin Ltd., Neopharma Corp., Pfizer Inc., Reckitt Benckiser Group Plc, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Virtus Pharmaceuticals LLC, Wockhardt Ltd., and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing awareness about bronchiectasis.'

According to the report, one of the major drivers for this market is the increasing cases of associated risk factors.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Akorn Operating Co LLC
  • Amneal Pharmaceuticals Inc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dr Reddys Laboratories Ltd.
  • Endo International Plc
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Lupin Ltd.
  • Neopharma Corp.
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Virtus Pharmaceuticals LLC
  • Wockhardt Ltd.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Bronchiectasis Drugs Market by Drug Class, Route of Administration, End-Users - Global Forecast 2025-2030 - Product Image

Bronchiectasis Drugs Market by Drug Class, Route of Administration, End-Users - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Bronchiectasis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Bronchiectasis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 89 Pages
  • Global
From
Sarcoidosis Therapeutics Market 2024-2028 - Product Image

Sarcoidosis Therapeutics Market 2024-2028

  • Report
  • 158 Pages
  • Global
From
Montelukast Sodium Market 2024-2028 - Product Image

Montelukast Sodium Market 2024-2028

  • Report
  • 140 Pages
  • Global
From
Tuberculosis Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032 - Product Image

Tuberculosis Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032

  • Report
  • 178 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.